+467.0%
MRNA vs FOXA
+16.6%
+450.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FOXA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.2% | +4.2% | +5.4% |
| 7D | -1.1% | +0.8% | -1.9% | -1.1% |
| 30D | +126.1% | +5.0% | +121.1% | +122.0% |
| 3M | +190.0% | -3.0% | +193.1% | +184.9% |
| 6M | +157.2% | +14.8% | +142.5% | +134.2% |
| YTD | +388.2% | -8.9% | +397.1% | +421.9% |
| 1Y | +467.0% | +13.3% | +453.7% | +416.4% |
| All | +467.0% | +16.6% | +450.5% | +416.4% |
Cumulative growth
Daily Returns
Daily percentage return beside FOXA.
Daily Out/Under-Performance
Portfolio return minus FOXA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FOXA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FOXA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling